Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection

Collateral damage of using colistin in hospitalized patients on emergence of colistin-resistant Escherichia coli and Klebsiella pneumoniae colonization and infection

Abstract Background Colistin has been used for therapy of carbapenem-resistant Gram-negative infections in Thailand, especially carbapenem-resistant A. baumannii and P. aeruginosa, for more than 10 years. However, the prevalence of colistin-resistant A. baumannii or P. aeruginosa is still less than...

Full description

Bibliographic Details
Main Authors: W. Wangchinda, N. Pati, N. Maknakhon, C. Seenama, S. Tiengrim, V. Thamlikitkul
Format: Article
Language:English
Published: BMC 2018-07-01
Series:Antimicrobial Resistance and Infection Control
Subjects:
Thailand
Prevalence
Colonization
Colistin-resistant Escherichia coli
Colistin-resistant Klebsiella pneumoniae
Colistin
Online Access:http://link.springer.com/article/10.1186/s13756-018-0375-4

Internet

http://link.springer.com/article/10.1186/s13756-018-0375-4

Similar Items